Glioblastoma multiforme: Diagnosis, treatment, and invasion

被引:10
|
作者
Li, Jiawei [1 ,2 ]
Feng, Lili [3 ,4 ]
Lu, Yingmei [1 ,5 ]
机构
[1] Nanjing Med Univ, Sch Basic Med Sci, Dept Physiol, Nanjing 211166, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Clin Med Coll 1, Nanjing 211166, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Drug Target & Drug Discovery Ctr, Sch Pharm, Key Lab Cardiovasc & Cerebrovascular Med, Nanjing 211166, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Drug Target & Drug Discovery Ctr, Sch Pharm, Key Lab Cardiovasc & Cerebrovascular Med, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China
[5] Nanjing Med Univ, Sch Basic Med Sci, Dept Physiol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China
来源
JOURNAL OF BIOMEDICAL RESEARCH | 2023年 / 37卷 / 01期
基金
中国国家自然科学基金;
关键词
glioblastoma multiforme; diagnosis; treatment; patterns of invasion; invasion mechanism; P53; CANCER; METASTASIS; THERAPY; GLIOMA; CELLS; EGFR;
D O I
10.7555/JBR.36.20220156
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Glioblastoma multiforme (GBM) is an essentially incurable brain tumor, which has been explored for approximately a century. Nowadays, surgical resection, chemotherapy, and radiation therapy are still the standardized therapeutic options. However, due to the intrinsic invasion and metastasis features and the resistance to chemotherapy, the survival rate of glioblastoma patients remains unsatisfactory. To improve the current situation, much more research is needed to provide comprehensive knowledge of GBM. In this review, we summarize the latest updates on GBM treatment and invasion. Firstly, we review the traditional and emerging therapies that have been used for GBM treatment. Given the limited efficiency of these therapies, we further discuss the role of invasion in GBM recurrence and progression, and present current research progress on the mode and mechanisms of GBM invasion.
引用
收藏
页码:47 / 58
页数:13
相关论文
共 50 条
  • [1] Glioblastoma multiforme:Diagnosis, treatment, and invasion
    Jiawei Li
    Lili Feng
    Yingmei Lu
    The Journal of Biomedical Research, 2023, 37 (01) : 47 - 58
  • [2] TREATMENT DISPARITIES FOLLOWING DIAGNOSIS OF A GLIOBLASTOMA MULTIFORME
    Sherwood, Paula R.
    Dahman, Bassam
    Donovan, Heidi
    Mintz, Arlan H.
    Given, Charles
    Bradley, Cathy
    NEURO-ONCOLOGY, 2009, 11 (05) : 582 - 582
  • [3] Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review
    Batash, Ron
    Asna, Noam
    Schaffer, Pamela
    Francis, Nicole
    Schaffer, Moshe
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (27) : 3002 - 3009
  • [4] The role of autotaxin in glioblastoma multiforme invasion
    Hoelzinger, DB
    Mariani, L
    Nakada, M
    Demuth, TD
    Beaudry, CE
    Coons, SW
    Berens, ME
    Gen, T
    NEURO-ONCOLOGY, 2004, 6 (04) : 310 - 310
  • [5] Leptomeningeal and ependymal invasion by glioblastoma multiforme
    Begemann, M
    Tsiouris, AJ
    Malkin, MG
    NEUROLOGY, 2004, 63 (03) : E8 - E8
  • [6] Invasion as target for therapy of glioblastoma multiforme
    Vehlow, Anne
    Cordes, Nils
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1836 (02): : 236 - 244
  • [7] Regional skin invasion by glioblastoma multiforme
    Wang, Tse-Lun
    Lin, Chih-Lung
    Tsai, Shan-Yin
    Lieu, Ann-Shung
    FORMOSAN JOURNAL OF SURGERY, 2015, 48 (05) : 172 - 176
  • [8] Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
    Zhao, Jianyi
    Lin, Yingying
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Vascular Distribution of Glioblastoma Multiforme at Diagnosis
    Yohay, K.
    Wolf, D. S.
    Aronson, L. J.
    Duus, M.
    Melhem, E. R.
    Cohen, K. J.
    INTERVENTIONAL NEURORADIOLOGY, 2013, 19 (01) : 127 - 131
  • [10] Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment
    Stoyanov, George S.
    Dzhenkov, Deyan
    Ghenev, Peter
    Iliev, Bogomil
    Enchev, Yavor
    Tonchev, Anton B.
    MEDICAL ONCOLOGY, 2018, 35 (03)